Contraceptive eligibility for women at high risk of HIV The World Health Organization (WHO) convened a Guideline Development Group (GDG) meeting from 29 to 31 July 2019 to review global guidance on contraceptive eligibility for women at high risk of HIV acquisition to...
WHO revises recommendations on hormonal contraceptive use for women at high HIV risk The World Health Organization (WHO) has revised its guidance on contraceptive use to reflect new evidence that women at high risk of HIV can use any form of reversible contraception,...
ECHO Study Master Q&A This Q&A covers background information, next steps, and implications following the results of the ECHO Study. Published: 2019 Source: WHO Back to...
Key messaging for policy-makers, programme managers, healthcare workersand women in response to the results of the ECH) study ECHO shows no statistically significant difference in risk of acquiring HIV among users of the three methods. This guidance document provides...
Hormonal contraceptive methods and HIV acquisition in women Joint statement from WHO, UNAIDS and UNFPA on the results the Evidence for Contraceptive Options and HIV Outcomes (ECHO) study conducted in four African countries and published in the Lancet. The study...
Recent Comments